Trials / Unknown
UnknownNCT05694845
Evaluation of the Patient's Experience in Medical Studies for Cholangiocarcinoma
A Clinical Study Experiences of Cholangiocarcinoma Patients To Identify Trial Attributes Affecting Completion Rates For Specific Demographic Groups
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Power Life Sciences Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main reason for conducting this research is to gain a better understanding of why some people with cholangiocarcinoma are not able to participate in or complete clinical trials. Historically, certain groups of people have been more likely to participate in clinical trials, but there hasn't been much research to understand why this is the case. The goal is to find out which aspects of a clinical trial may make it more difficult for patients to take part or see it through. The data will be evaluated through different demographic lenses and identify trends that could help improve the experience of future cholangiocarcinoma patients during clinical trials.
Conditions
Timeline
- Start date
- 2024-02-01
- Primary completion
- 2025-02-01
- Completion
- 2026-02-01
- First posted
- 2023-01-23
- Last updated
- 2023-03-06
Source: ClinicalTrials.gov record NCT05694845. Inclusion in this directory is not an endorsement.